Richard B. Silverman

14.4k total citations · 1 hit paper
401 papers, 11.8k citations indexed

About

Richard B. Silverman is a scholar working on Molecular Biology, Physiology and Organic Chemistry. According to data from OpenAlex, Richard B. Silverman has authored 401 papers receiving a total of 11.8k indexed citations (citations by other indexed papers that have themselves been cited), including 197 papers in Molecular Biology, 119 papers in Physiology and 109 papers in Organic Chemistry. Recurrent topics in Richard B. Silverman's work include Nitric Oxide and Endothelin Effects (102 papers), Amino Acid Enzymes and Metabolism (45 papers) and Chemical Synthesis and Analysis (43 papers). Richard B. Silverman is often cited by papers focused on Nitric Oxide and Endothelin Effects (102 papers), Amino Acid Enzymes and Metabolism (45 papers) and Chemical Synthesis and Analysis (43 papers). Richard B. Silverman collaborates with scholars based in United States, Czechia and Canada. Richard B. Silverman's co-authors include Pavel Martásek, Maris A. Cinelli, T.L. Poulos, Linda J. Roman, Ha T., Galen P. Miley, Jian Qiu, Richard I. Morimoto, Haitao Ji and Wenxin Gu and has published in prestigious journals such as Chemical Reviews, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Richard B. Silverman

396 papers receiving 11.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inducible nitric oxide synthase: Regulation, structure, and inhibition

2019 591 citations Maris A. Cinelli, Ha T. et al. profile →

Peers

Countries citing papers authored by Richard B. Silverman

Since Specialization

Citations

This map shows the geographic impact of Richard B. Silverman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard B. Silverman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard B. Silverman more than expected).

Fields of papers citing papers by Richard B. Silverman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard B. Silverman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard B. Silverman. The network helps show where Richard B. Silverman may publish in the future.

Co-authorship network of co-authors of Richard B. Silverman

This figure shows the co-authorship network connecting the top 25 collaborators of Richard B. Silverman. A scholar is included among the top collaborators of Richard B. Silverman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard B. Silverman. Richard B. Silverman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Synthesis of Oxabicyclo[3.2.1]octan-3-ol Scaffold via Burgess Reagent Mediated Cyclodehydration of δ-Diols under Acidic Conditions 2025 ·Organic Letters ·(unknown), (unknown), Richard B. Silverman	0
2	Reducing Off-Target Activity of CPP-115 by Targeting Conformational Flexibility of a Reactive Intermediate 2025 ·ChemRxiv ·(unknown), Richard B. Silverman	1
3	Crystallographic and Computational Insights into Isoform-Selective Dynamics in Nitric Oxide Synthase 2024 ·Biochemistry ·Huiying Li, Christine D. Hardy, (unknown), Qing Jing, Fengtian Xue, Maris A. Cinelli, Richard B. Silverman, T.L. Poulos	3
4	Design, Synthesis, and Mechanistic Studies of (R)-3-Amino-5,5-difluorocyclohex-1-ene-1-carboxylic Acid as an Inactivator of Human Ornithine Aminotransferase 2024 ·ACS Chemical Biology ·(unknown), A. Vargas, Wei Zhu, Benjamin J. Des Soye, Fatma Ayaloglu Butun, (unknown), (unknown), Gláucio Monteiro Ferreira, Graham R. Moran, Neil L. Kelleher, Dali Liu, Richard B. Silverman	2
5	Potent, Selective, and Membrane Permeable 2-Amino-4-Substituted Pyridine-Based Neuronal Nitric Oxide Synthase Inhibitors 2023 ·Journal of Medicinal Chemistry ·Dhananjayan Vasu, Ha T., Huiying Li, Christine D. Hardy, Amardeep Awasthi, T.L. Poulos, Richard B. Silverman	6
6	Structural and Mechanistic Basis for the Inactivation of Human Ornithine Aminotransferase by (3S,4S)-3-Amino-4-fluorocyclopentenecarboxylic Acid 2023 ·Molecules ·Sida Shen, (unknown), (unknown), Gláucio Monteiro Ferreira, Peter F. Doubleday, (unknown), Wei Zhu, Neil L. Kelleher, Graham R. Moran, Dali Liu, Richard B. Silverman	1
7	Target Identification of a Class of Pyrazolone Protein Aggregation Inhibitor Therapeutics for Amyotrophic Lateral Sclerosis 2023 ·ACS Central Science ·Pathum M. Weerawarna, Isaac T. Schiefer, Pedro Soares, Susan G. Fox, Richard I. Morimoto, Rafael D. Melani, Neil L. Kelleher, Chi‐Hao Luan, Richard B. Silverman	2
8	Rational Design, Synthesis, and Mechanism of (3S,4R)-3-Amino-4-(difluoromethyl)cyclopent-1-ene-1-carboxylic Acid: Employing a Second-Deprotonation Strategy for Selectivity of Human Ornithine Aminotransferase over GABA Aminotransferase 2022 ·Journal of the American Chemical Society ·Wei Zhu, (unknown), Rafael D. Melani, Peter F. Doubleday, Gláucio Monteiro Ferreira, Maurício T. Tavares, (unknown), (unknown), Neil L. Kelleher, Graham R. Moran, Dali Liu, Richard B. Silverman	9
9	Remarkable and Unexpected Mechanism for (S)-3-Amino-4-(difluoromethylenyl)cyclohex-1-ene-1-carboxylic Acid as a Selective Inactivator of Human Ornithine Aminotransferase 2021 ·Journal of the American Chemical Society ·Wei Zhu, Peter F. Doubleday, (unknown), Pathum M. Weerawarna, Rafael D. Melani, (unknown), Timothy A. Dwight, Dali Liu, Neil L. Kelleher, Richard B. Silverman	13
10	Turnover and Inactivation Mechanisms for (S)-3-Amino-4,4-difluorocyclopent-1-enecarboxylic Acid, a Selective Mechanism-Based Inactivator of Human Ornithine Aminotransferase 2021 ·Journal of the American Chemical Society ·Sida Shen, (unknown), Peter F. Doubleday, Rafael D. Melani, (unknown), Maurício T. Tavares, Gláucio Monteiro Ferreira, Neil L. Kelleher, Graham R. Moran, Dali Liu, Richard B. Silverman	9
11	A Remarkable Difference That One Fluorine Atom Confers on the Mechanisms of Inactivation of Human Ornithine Aminotransferase by Two Cyclohexene Analogues of γ-Aminobutyric Acid 2020 ·Journal of the American Chemical Society ·Wei Zhu, Peter F. Doubleday, (unknown), Pathum M. Weerawarna, (unknown), Sida Shen, Z. Wawrzak, Neil L. Kelleher, Dali Liu, Richard B. Silverman	25
12	Structural and Kinetic Analyses Reveal the Dual Inhibition Modes of Ornithine Aminotransferase by (1S,3S)-3-Amino-4-(hexafluoropropan-2-ylidenyl)-cyclopentane-1-carboxylic Acid (BCF₃) 2020 ·ACS Chemical Biology ·(unknown), (unknown), (unknown), Peidong Zhao, Sida Shen, Richard B. Silverman, Graham R. Moran, Dali Liu	5
13	(S)‐4‐Amino‐5‐phenoxypentanoate designed as a potential selective agonist of the bacterial transcription factor GabR 2020 ·Protein Science ·(unknown), (unknown), (unknown), Richard B. Silverman, (unknown), Daniel P. Becker, Dali Liu	2
14	Mechanism of Inactivation of Ornithine Aminotransferase by (1S,3S)-3-Amino-4-(hexafluoropropan-2-ylidenyl)cyclopentane-1-carboxylic Acid 2019 ·Journal of the American Chemical Society ·(unknown), Peter F. Doubleday, (unknown), Neil L. Kelleher, Dali Liu, Richard B. Silverman	20
15	A modulator of wild-type glucocerebrosidase improves pathogenic phenotypes in dopaminergic neuronal models of Parkinson’s disease 2019 ·Science Translational Medicine ·Lena F. Burbulla, Sohee Jeon, Jianbin Zheng, Pingping Song, Richard B. Silverman, Dimitri Krainc	84
16	Design and Mechanism of (S)-3-Amino-4-(difluoromethylenyl)cyclopent-1-ene-1-carboxylic Acid, a Highly Potent γ-Aminobutyric Acid Aminotransferase Inactivator for the Treatment of Addiction 2018 ·Journal of the American Chemical Society ·(unknown), (unknown), Hoang V. Le, (unknown), Pathum M. Weerawarna, (unknown), Dali Liu, Stephen L. Dewey, Richard B. Silverman	56
17	Selective Targeting by a Mechanism-Based Inactivator against Pyridoxal 5′-Phosphate-Dependent Enzymes: Mechanisms of Inactivation and Alternative Turnover 2017 ·Biochemistry ·(unknown), Hoang V. Le, Kenneth D. Clevenger, (unknown), Dagmar Ringe, Neil L. Kelleher, Richard B. Silverman, Dali Liu	13
18	Do Anesthesia Residents perceive a Benefit from participating in Bedside Tracheostomies? 2014 ·PubMed ·Richard B. Silverman, (unknown)	2
19	Potent, Highly Selective, and Orally Bioavailable Gem -Difluorinated Monocationic Inhibitors of Neuronal Nitric Oxide Synthase 2010 ·Journal of the American Chemical Society ·Fengtian Xue, Huiying Li, S.L. Delker, Jianguo Fang, Pavel Martásek, Linda J. Roman, T.L. Poulos, Richard B. Silverman	62
20	Bis[2,3-butanedionedioximato (1-)]cobalt Complexes 1980 ·John E. Bulkowski, (unknown), David Dolphin, Richard B. Silverman	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact